Hyalex Orthopaedics Appoints Carl Vause, Orthopaedic Industry Veteran, as Chief Executive Officer and President and Names Mike Hawkins, Ph.D., Chief Technical Officer
- Hyalex Orthopaedics
LEXINGTON, Mass., Jan. 25, 2022 /PRNewswire/ — Hyalex Orthopaedics, a privately-held medical device company developing transformational cartilage biomimetic products, today announced the appointment of Carl Vause as its new chief executive officer and president. Mr. Vause, who succeeds Hyalex’s interim president, Michael Hawkins, Ph.D., has also been appointed to the company’s board of directors. Additionally, Dr. Hawkins has been named chief technical officer and will continue to serve as a director on the company’s board. Read more…
Related Reading
Blog / Small Business
Medical Technology Start-ups Get a Critical Boost Via “America’s Seed Fund”
May 11, 2022
The federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs support scientific development and product innovation benefiting patients in need and the public at large.
Event / Small Business
MedTech Investment Working Group – Quarterly Meeting
March 10, 2022
1:00 PM
The Q1 2022 meeting focuses on the diagnostics industry with presentations from Susan Van Meter, Executive Director of AdvaMedDx and a discussion panel on deal-making in diagnostics.
Event / Small Business
NIH SBIR/STTR Proposal Workshop
June 7 & 9, 2022
For basic research advancing beyond the academic realm, the National Institutes of Health (NIH) provides non-dilutive federal funding through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. The NIH SBIR/STTR programs award over $1.21 billion in R&D funding annually to qualified small businesses developing game-changing technologies. This three-part workshop is ideal for companies targeting the September 5 submission deadline.
Event / Regulatory Affairs / Small Business
The Innovation Roadmap™ for Medical Device Development: Fostering Innovation & Optimum Programmatic Direction Under Strategic Regulatory Deployment
March 24, 2022
12:00 PM
Blog / Small Business
Combat Veteran, CEO and Veterans Advocate Derek Herrera Talks with AdvaMed’s Scott Whitaker on Pursuing New Missions in MedTech
February 25, 2022
Derek Herrera, leader of Bright Uro Inc. and MedTechVets, joined the most recent episode of the MedTech POV podcast to share his insights.
News / Small Business
MedTech POV with Scott Whitaker | Guest Derek Herrera, Marine Veteran injured in Afghanistan, Discusses His Journey, from the Battlefield to Supporting Veterans in MedTech and Becoming an Entrepreneur
February 23, 2022
Derek Herrera, former Marine and current Board President of MedTechVets and Founder and CEO of Bright Uro, joined AdvaMed’s Scott Whitaker on the MedTech POV podcast to talk about his experiences, from his paralysis by a sniper’s bullet in Afghanistan to his subsequent career as a medtech entrepreneur, and what he sees for the future of the industry.
News / Global & Trade / Small Business
AdvaMed Announces Opening of Nomination Period for 10th Annual Lifetime Achievement Award
February 2, 2022
AdvaMed announced today that the nomination period for its 10th annual Lifetime Achievement Award is now open. The award will be presented at The MedTech Conference, which will be held in Boston in October.
Resource / Digital Health / Global & Trade / Legal & Compliance / Regulatory Affairs / Small Business
Trendspotting 2022: On the Pulse of Life Sciences
January 31, 2022
Sidley’s Global Life Sciences group looks at 12 forces driving the life sciences legal and regulatory landscape in 2022, and provides practical tips on a range of topics for life sciences companies and investors seeking to navigatte through, and capitalize on, this complex environment.